Fundies. English
Segment disclosures
Company overviewMirion Technologies, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
52 dimension combinations 693 retained observations 26 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Industrial Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=mir:IndustrialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 446100000 | USD | 20230228 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 103100000 | USD | 20220505 | Open filing evidence |
| 2021-10-21 – 2021-12-31 | 104900000 | USD | 20230228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 104900000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 107700000 | USD | 20230228 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 455900000 | USD | 20230228 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 114700000 | USD | 20220505 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 415600000 | USD | 20230228 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 397200000 | USD | 20220228 | Open filing evidence |
Operating Segments · Medical Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 66400000 | USD | 20230503 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 271700000 | USD | 20230228 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 60100000 | USD | 20230503 | Open filing evidence |
| 2021-10-21 – 2021-12-31 | 49200000 | USD | 20230228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 49200000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 60300000 | USD | 20230228 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 155700000 | USD | 20230228 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 62600000 | USD | 20230228 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 42900000 | USD | 20220228 | Open filing evidence |
Operating Segments · Technologies Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=mir:TechnologiesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 516400000 | USD | 20240228 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 446100000 | USD | 20240228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 104900000 | USD | 20240228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 107700000 | USD | 20240228 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 455900000 | USD | 20240228 | Open filing evidence |
Cancer Care · Medical Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mir:CancerCareMember;us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 62800000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 118100000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 55300000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 237000000 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 62000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 173100000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 62200000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 111100000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 51000000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 228100000 | USD | 20260219 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 57100000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 162100000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 56000000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 105000000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 48900000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 215900000 | USD | 20260219 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 206000000 | USD | 20250226 | Open filing evidence |
Labs And Research · Nuclear Safety Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mir:LabsAndResearchMember;us-gaap:StatementBusinessSegmentsAxis=mir:NuclearSafetySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 29100000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 57400000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 28300000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 122200000 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 34000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 88200000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 27400000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 54200000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 26800000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 131700000 | USD | 20260219 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 35400000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 95100000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 26700000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 59700000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 33000000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 122900000 | USD | 20260219 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 103100000 | USD | 20250226 | Open filing evidence |
Medical · Medical Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mir:MedicalMember;us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 74100000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 214100000 | USD | 20241030 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 73200000 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 140000000 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 66800000 | USD | 20240501 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 68800000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 203200000 | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 68000000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 134400000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 66400000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 271700000 | USD | 20230228 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 68700000 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 195600000 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 60100000 | USD | 20230503 | Open filing evidence |
| 2021-10-21 – 2021-12-31 | 49200000 | USD | 20230228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 49200000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 60300000 | USD | 20230228 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 155700000 | USD | 20230228 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 51500000 | USD | 20220505 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 62600000 Restated | USD | 20230228 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 42900000 | USD | 20220228 | Open filing evidence |
Nuclear · Nuclear Safety Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mir:NuclearMember;us-gaap:StatementBusinessSegmentsAxis=mir:NuclearSafetySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 374600000 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 81800000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 248100000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 82100000 | USD | 20250801 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 166300000 | USD | 20250801 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 84100000 | USD | 20250430 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 316600000 | USD | 20260219 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 71300000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 218800000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 76000000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 147500000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 71500000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 291800000 | USD | 20260219 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 254200000 | USD | 20250226 | Open filing evidence |
Nuclear Power · Nuclear Safety Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mir:NuclearPowerMember;us-gaap:StatementBusinessSegmentsAxis=mir:NuclearSafetySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 118100000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 243900000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 125800000 | USD | 20260429 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 82100000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 166300000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 84100000 | USD | 20260429 | Open filing evidence |
Other Care · Medical Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mir:OtherCareMember;us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 17800000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 34600000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 16800000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 73800000 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 16500000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 55200000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 19000000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 38700000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 17600000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 71600000 | USD | 20260219 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 17000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 52000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 17200000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 35000000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 17900000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 68600000 | USD | 20260219 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 65800000 | USD | 20250226 | Open filing evidence |
Other Research · Nuclear Safety Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mir:OtherResearchMember;us-gaap:StatementBusinessSegmentsAxis=mir:NuclearSafetySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 39000000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 70400000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 31400000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 117800000 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 28800000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 83400000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 32200000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 54600000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 22500000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 112800000 | USD | 20260219 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 26000000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 78500000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 31200000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 52500000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 21300000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 101700000 | USD | 20260219 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 88700000 | USD | 20250226 | Open filing evidence |
Radiological Search Measurement And Analysis Systems · Industrial Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mir:RadiologicalSearchMeasurementAndAnalysisSystemsMember;us-gaap:StatementBusinessSegmentsAxis=mir:IndustrialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 68500000 | USD | 20221103 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 215100000 | USD | 20221103 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 74300000 | USD | 20220729 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 146600000 | USD | 20220729 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 74300000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 73000000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 62900000 | USD | 20221103 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 225900000 | USD | 20221103 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 85200000 | USD | 20220729 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 163000000 | USD | 20220729 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 309100000 | USD | 20220228 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 280200000 | USD | 20220228 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 263900000 | USD | 20220228 | Open filing evidence |
Radiological Search Measurement And Analysis Systems · Technologies Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mir:RadiologicalSearchMeasurementAndAnalysisSystemsMember;us-gaap:StatementBusinessSegmentsAxis=mir:TechnologiesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 78200000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 229300000 | USD | 20241030 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 75600000 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 151100000 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 75500000 | USD | 20240501 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 73700000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 225400000 | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 78100000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 151700000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 73600000 | USD | 20240501 | Open filing evidence |
Reactor Safety And Control Systems · Industrial Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mir:ReactorSafetyAndControlSystemsMember;us-gaap:StatementBusinessSegmentsAxis=mir:IndustrialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 51100000 | USD | 20230803 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 93200000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 163800000 | USD | 20230228 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 23700000 | USD | 20221103 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 89200000 | USD | 20221103 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 34700000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 65500000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 30800000 | USD | 20220505 | Open filing evidence |
| 2021-10-21 – 2021-12-31 | 30600000 | USD | 20230228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 30600000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 34700000 | USD | 20230228 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 29400000 | USD | 20221103 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 109000000 | USD | 20221103 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 42700000 | USD | 20220729 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 79600000 | USD | 20220729 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 146800000 | USD | 20230228 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 36900000 | USD | 20220505 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 135400000 | USD | 20230228 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 133300000 | USD | 20220228 | Open filing evidence |
Reactor Safety And Control Systems · Technologies Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=mir:ReactorSafetyAndControlSystemsMember;us-gaap:StatementBusinessSegmentsAxis=mir:TechnologiesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 54500000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 163100000 | USD | 20241030 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 58300000 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 108600000 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 50300000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 204000000 | USD | 20240228 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 48700000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 141900000 | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 51100000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 93200000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 42100000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 163800000 | USD | 20240228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 30600000 | USD | 20240228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 34700000 | USD | 20240228 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 146800000 | USD | 20240228 | Open filing evidence |
Asia Pacific · Industrial Segment
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:AsiaPacificMember;us-gaap:StatementBusinessSegmentsAxis=mir:IndustrialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 7400000 | USD | 20230503 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 13300000 | USD | 20230228 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 1300000 | USD | 20220729 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 9000000 | USD | 20220729 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 7700000 | USD | 20230503 | Open filing evidence |
| 2021-10-21 – 2021-12-31 | 2000000 | USD | 20230228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 1700000 | USD | 20230228 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 1800000 | USD | 20220729 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 11000000 | USD | 20220729 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 15000000 | USD | 20230228 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 9200000 | USD | 20220505 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 16000000 | USD | 20230228 | Open filing evidence |
Asia Pacific · Medical Segment
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:AsiaPacificMember;us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 0 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260219 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 0 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 0 | USD | 20260219 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230503 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 0 | USD | 20250226 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20220729 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20220729 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 0 | USD | 20230503 | Open filing evidence |
| 2021-10-21 – 2021-12-31 | 0 | USD | 20230228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 0 | USD | 20240228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 0 | USD | 20240228 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 0 | USD | 20220729 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 0 | USD | 20220729 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 0 | USD | 20240228 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 0 | USD | 20220505 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 0 | USD | 20230228 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 0 | USD | 20220228 | Open filing evidence |
Asia Pacific · Nuclear Safety Segment
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:AsiaPacificMember;us-gaap:StatementBusinessSegmentsAxis=mir:NuclearSafetySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 2600000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 7300000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 4700000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 15600000 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 3200000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 11200000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2200000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 8000000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 5800000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 13000000 | USD | 20260219 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2900000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 10000000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1200000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 7000000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 5800000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 16500000 | USD | 20260219 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 13300000 | USD | 20250226 | Open filing evidence |
Asia Pacific · Technologies Segment
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:AsiaPacificMember;us-gaap:StatementBusinessSegmentsAxis=mir:TechnologiesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 2900000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 10000000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 16500000 | USD | 20240228 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1900000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 11000000 | USD | 20241030 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 13300000 | USD | 20240228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 2000000 | USD | 20240228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 1700000 | USD | 20240228 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 15000000 | USD | 20240228 | Open filing evidence |
Europe · Industrial Segment
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=mir:IndustrialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 63400000 | USD | 20230803 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 116500000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 222100000 | USD | 20230228 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 57900000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 111100000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 53200000 | USD | 20220505 | Open filing evidence |
| 2021-10-21 – 2021-12-31 | 55300000 | USD | 20230228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 55300000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 52600000 | USD | 20230228 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 65000000 | USD | 20220729 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 126700000 | USD | 20220729 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 241500000 | USD | 20230228 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 61700000 | USD | 20220505 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 206200000 | USD | 20230228 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 194900000 | USD | 20220228 | Open filing evidence |
Europe · Medical Segment
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 7500000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 14800000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 7300000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 31500000 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 8700000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 23700000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 8400000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 15000000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 6600000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 27800000 | USD | 20260219 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 6500000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 19800000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 7000000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 13400000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 6400000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 26400000 | USD | 20260219 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 6700000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 18200000 | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5800000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 11500000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 5700000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 19700000 | USD | 20250226 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 4500000 | USD | 20230503 | Open filing evidence |
| 2021-10-21 – 2021-12-31 | 3900000 | USD | 20230228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 3900000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 5700000 | USD | 20230228 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 17100000 | USD | 20230228 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 4300000 | USD | 20220505 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 5200000 | USD | 20230228 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 1900000 | USD | 20220228 | Open filing evidence |
Europe · Nuclear Safety Segment
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=mir:NuclearSafetySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 77600000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 148200000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 70600000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 296100000 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 67000000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 199200000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 73400000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 132200000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 58900000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 277800000 | USD | 20260219 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 58800000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 190300000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 70100000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 131500000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 61400000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 245700000 | USD | 20260219 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 222100000 | USD | 20250226 | Open filing evidence |
Europe · Technologies Segment
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=mir:TechnologiesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 58800000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 190300000 | USD | 20241030 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 70100000 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 131500000 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 61400000 | USD | 20240501 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 50700000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 167200000 | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 63400000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 116500000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 53100000 | USD | 20240501 | Open filing evidence |
North America · Industrial Segment
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=mir:IndustrialSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 64100000 | USD | 20230803 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 119300000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 210700000 | USD | 20230228 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 49700000 | USD | 20221103 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 141800000 | USD | 20221103 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 49800000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 92000000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 42200000 | USD | 20220505 | Open filing evidence |
| 2021-10-21 – 2021-12-31 | 47600000 | USD | 20230228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 47600000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 53400000 | USD | 20230228 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 47300000 | USD | 20221103 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 152200000 | USD | 20221103 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 61100000 | USD | 20220729 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 104900000 | USD | 20220729 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 199400000 | USD | 20230228 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 43800000 | USD | 20220505 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 193300000 | USD | 20230228 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 188300000 | USD | 20220228 | Open filing evidence |
North America · Medical Segment
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 73100000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 137900000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 64800000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 279300000 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 69800000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 204600000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 72800000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 134800000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 62000000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 271900000 | USD | 20260219 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 67700000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 194300000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 66200000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 126600000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 60400000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 258100000 | USD | 20260219 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 62100000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 185000000 | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 62200000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 122900000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 60700000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 252000000 | USD | 20250226 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 63700000 | USD | 20221103 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 181000000 | USD | 20221103 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 55600000 | USD | 20230503 | Open filing evidence |
| 2021-10-21 – 2021-12-31 | 45300000 | USD | 20230228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 45300000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 54600000 | USD | 20230228 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 47300000 | USD | 20221103 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 141200000 | USD | 20221103 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 138600000 | USD | 20230228 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 57500000 | USD | 20230228 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 41000000 | USD | 20220228 | Open filing evidence |
North America · Nuclear Safety Segment
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=mir:NuclearSafetySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 106000000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 216200000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 110200000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 302900000 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 74400000 | USD | 20251029 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 209300000 | USD | 20251029 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 66100000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 134900000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 68700000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 270300000 | USD | 20260219 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 70900000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 192100000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 62600000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 121200000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 58600000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 254200000 | USD | 20260219 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 210700000 | USD | 20250226 | Open filing evidence |
North America · Technologies Segment
Statement Geographical · Statement Business Segments
Source dimensions
srt:StatementGeographicalAxis=srt:NorthAmericaMember;us-gaap:StatementBusinessSegmentsAxis=mir:TechnologiesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 70900000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 192100000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 58600000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 254200000 | USD | 20240228 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 69800000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 189100000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 55200000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 210700000 | USD | 20240228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 47600000 | USD | 20240228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 53400000 | USD | 20240228 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 199400000 | USD | 20240228 | Open filing evidence |
Industrial Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:IndustrialSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 122400000 | USD | 20231102 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 367300000 | USD | 20231102 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 129200000 | USD | 20230803 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 244900000 | USD | 20230803 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 115700000 | USD | 20230503 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 92200000 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 304300000 | USD | 20231102 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 109000000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 212100000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 103100000 | USD | 20230503 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 92300000 | USD | 20221103 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 334900000 | USD | 20221103 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 127900000 | USD | 20220729 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 242600000 | USD | 20220729 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 455900000 | USD | 20211027 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 415600000 | USD | 20211027 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 397200000 | USD | 20211027 | Open filing evidence |
Industrial Segment · Radiological Search Measurement And Analysis Systems
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:IndustrialSegmentMember;srt:ProductOrServiceAxis=mir:RadiologicalSearchMeasurementAndAnalysisSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 73700000 | USD | 20231102 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 225400000 | USD | 20231102 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 78100000 | USD | 20230803 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 151700000 | USD | 20230803 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 73600000 | USD | 20230503 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 282300000 | USD | 20230228 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 68500000 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 215100000 | USD | 20231102 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 74300000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 146600000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 72300000 | USD | 20230503 | Open filing evidence |
| 2021-10-21 – 2021-12-31 | 74300000 | USD | 20230228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 73000000 | USD | 20230228 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 309100000 | USD | 20230228 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 77800000 | USD | 20220505 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 280200000 | USD | 20230228 | Open filing evidence |
Industrial Segment · Reactor Safety And Control Systems
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:IndustrialSegmentMember;srt:ProductOrServiceAxis=mir:ReactorSafetyAndControlSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 48700000 | USD | 20231102 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 141900000 | USD | 20231102 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 42100000 | USD | 20230503 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 23700000 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 89200000 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 30800000 | USD | 20230503 | Open filing evidence |
Industrial Segment · Asia Pacific
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:IndustrialSegmentMember;srt:StatementGeographicalAxis=srt:AsiaPacificMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 1900000 | USD | 20231102 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 11000000 | USD | 20231102 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1700000 | USD | 20230803 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 9100000 | USD | 20230803 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 1500000 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 10400000 | USD | 20231102 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 1300000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 9000000 | USD | 20230803 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 2000000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 1700000 | USD | 20220228 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 1500000 | USD | 20221103 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 12500000 | USD | 20221103 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 15000000 | USD | 20220228 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 16000000 | USD | 20220228 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 14000000 | USD | 20220228 | Open filing evidence |
Industrial Segment · Europe
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:IndustrialSegmentMember;srt:StatementGeographicalAxis=srt:EuropeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 50700000 | USD | 20231102 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 167200000 | USD | 20231102 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 53100000 | USD | 20230503 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 40900000 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 152000000 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 53200000 | USD | 20230503 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 43500000 | USD | 20221103 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 170200000 | USD | 20221103 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 241500000 | USD | 20211027 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 206200000 | USD | 20211027 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 194900000 | USD | 20211027 | Open filing evidence |
Industrial Segment · North America
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:IndustrialSegmentMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 69800000 | USD | 20231102 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 189100000 | USD | 20231102 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 55200000 | USD | 20230503 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 49700000 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 141800000 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 42200000 | USD | 20230503 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 199400000 | USD | 20211027 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 193300000 | USD | 20211027 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 188300000 | USD | 20211027 | Open filing evidence |
Medical Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 83800000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 236500000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 80600000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 152700000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 72100000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 310800000 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 78500000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 228300000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 81200000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 149800000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 68600000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 299700000 | USD | 20260219 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 74100000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 214100000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 73200000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 140000000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 66800000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 284500000 | USD | 20260219 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 68800000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 203200000 | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 68000000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 134400000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 66400000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 271700000 | USD | 20250226 | Open filing evidence |
Medical Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 284500000 | USD | 20240228 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 68800000 | USD | 20231102 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 203200000 | USD | 20231102 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 68000000 | USD | 20230803 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 134400000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 271700000 | USD | 20240228 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 68700000 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 195600000 | USD | 20231102 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 66800000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 126900000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 60100000 | USD | 20220505 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 49200000 | USD | 20240228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 60300000 | USD | 20240228 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 52000000 | USD | 20221103 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 155600000 | USD | 20221103 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 52100000 | USD | 20220729 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 103600000 | USD | 20220729 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 155700000 | USD | 20240228 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 51500000 | USD | 20220505 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 62600000 | USD | 20211027 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 42900000 | USD | 20211027 | Open filing evidence |
Medical Segment · Cancer Care
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember;srt:ProductOrServiceAxis=mir:CancerCareMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 64700000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 182800000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 62000000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 173100000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
Medical Segment · Medical
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember;srt:ProductOrServiceAxis=mir:MedicalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 284500000 | USD | 20240228 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 68000000 | USD | 20230803 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 134400000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 271700000 | USD | 20240228 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 68700000 | USD | 20221103 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 195600000 | USD | 20221103 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 66800000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 126900000 | USD | 20230803 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 49200000 | USD | 20240228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 60300000 | USD | 20240228 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 52000000 | USD | 20221103 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 155600000 | USD | 20221103 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 52100000 | USD | 20220729 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 103600000 | USD | 20220729 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 155700000 | USD | 20240228 | Open filing evidence |
Medical Segment · Other Care
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember;srt:ProductOrServiceAxis=mir:OtherCareMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 19100000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 53700000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 16500000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 55200000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
Medical Segment · Asia Pacific
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember;srt:StatementGeographicalAxis=srt:AsiaPacificMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 0 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 0 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 0 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 0 | USD | 20240501 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20231102 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20231102 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20240501 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 0 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20231102 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20230803 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 0 | USD | 20221103 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 0 | USD | 20221103 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 0 | USD | 20211027 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 0 | USD | 20211027 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 0 | USD | 20211027 | Open filing evidence |
Medical Segment · Europe
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember;srt:StatementGeographicalAxis=srt:EuropeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 8600000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 23400000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 8700000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 23700000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 26400000 | USD | 20240228 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 6700000 | USD | 20231102 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 18200000 | USD | 20231102 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 5800000 | USD | 20230803 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 11500000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 19700000 | USD | 20240228 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 5100000 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 14700000 | USD | 20231102 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 5100000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 9600000 | USD | 20230803 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 3900000 | USD | 20240228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 5700000 | USD | 20240228 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 4700000 | USD | 20221103 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 14400000 | USD | 20221103 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 5400000 | USD | 20220729 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 9700000 | USD | 20220729 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 17100000 | USD | 20240228 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 5200000 | USD | 20211027 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 1900000 | USD | 20211027 | Open filing evidence |
Medical Segment · North America
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:MedicalSegmentMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 75200000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 213100000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 69800000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 204600000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 258100000 | USD | 20240228 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 62100000 | USD | 20231102 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 185000000 | USD | 20231102 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 62200000 | USD | 20230803 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 122900000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 252000000 | USD | 20240228 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 63700000 | USD | 20231102 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 181000000 | USD | 20231102 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 61700000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 117300000 | USD | 20230803 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 55600000 | USD | 20220505 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 45300000 | USD | 20240228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 54600000 | USD | 20240228 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 46700000 | USD | 20220729 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 93900000 | USD | 20220729 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 138600000 | USD | 20240228 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 47200000 | USD | 20220505 | Open filing evidence |
| 2019-07-01 – 2020-06-30 | 57500000 | USD | 20211027 | Open filing evidence |
| 2018-07-01 – 2019-06-30 | 41000000 | USD | 20211027 | Open filing evidence |
Nuclear Safety Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:NuclearSafetySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 194000000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 565700000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 186200000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 371700000 | USD | 20260729 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 185500000 | USD | 20260429 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 614600000 | USD | 20260219 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 144600000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 419700000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 141700000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 275100000 | USD | 20260729 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 133400000 | USD | 20260429 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 561100000 | USD | 20260219 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 132700000 | USD | 20251029 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 392400000 | USD | 20251029 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 133900000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 259700000 | USD | 20250801 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 125800000 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 516400000 | USD | 20260219 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 446100000 | USD | 20250226 | Open filing evidence |
Nuclear Safety Segment · Labs And Research
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:NuclearSafetySegmentMember;srt:ProductOrServiceAxis=mir:LabsAndResearchMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 36200000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 93600000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 34000000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 88200000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
Nuclear Safety Segment · Nuclear Power
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:NuclearSafetySegmentMember;srt:ProductOrServiceAxis=mir:NuclearPowerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 126100000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 370000000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 81800000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 248100000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
Nuclear Safety Segment · Other Research
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:NuclearSafetySegmentMember;srt:ProductOrServiceAxis=mir:OtherResearchMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 31700000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 102100000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 28800000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 83400000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
Nuclear Safety Segment · Asia Pacific
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:NuclearSafetySegmentMember;srt:StatementGeographicalAxis=srt:AsiaPacificMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 2300000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 9600000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 3200000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 11200000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
Nuclear Safety Segment · Europe
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:NuclearSafetySegmentMember;srt:StatementGeographicalAxis=srt:EuropeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 68000000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 216200000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 67000000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 199200000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
Nuclear Safety Segment · North America
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:NuclearSafetySegmentMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 123700000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 339900000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 74400000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 209300000 | USD | 2026-10-28 · 20:06:07.000Z | Open filing evidence |
Technologies Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:TechnologiesSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 132700000 | USD | 20241030 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 392400000 | USD | 20241030 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 133900000 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 259700000 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 125800000 | USD | 20240501 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 122400000 | USD | 20241030 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 367300000 | USD | 20241030 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 129200000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 244900000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 115700000 | USD | 20240501 | Open filing evidence |
Technologies Segment · Radiological Search Measurement And Analysis Systems
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:TechnologiesSegmentMember;srt:ProductOrServiceAxis=mir:RadiologicalSearchMeasurementAndAnalysisSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 312400000 | USD | 20240228 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 282300000 | USD | 20240228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 74300000 | USD | 20240228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 73000000 | USD | 20240228 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 309100000 | USD | 20240228 | Open filing evidence |
Technologies Segment · Asia Pacific
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:TechnologiesSegmentMember;srt:StatementGeographicalAxis=srt:AsiaPacificMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 1200000 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 7000000 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 5800000 | USD | 20240501 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1700000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 9100000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 7400000 | USD | 20240501 | Open filing evidence |
Technologies Segment · Europe
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:TechnologiesSegmentMember;srt:StatementGeographicalAxis=srt:EuropeMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 245700000 | USD | 20240228 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 222100000 | USD | 20240228 | Open filing evidence |
| 2021-10-20 – 2021-12-31 | 55300000 | USD | 20240228 | Open filing evidence |
| 2021-07-01 – 2021-10-19 | 52600000 | USD | 20240228 | Open filing evidence |
| 2020-07-01 – 2021-06-30 | 241500000 | USD | 20240228 | Open filing evidence |
Technologies Segment · North America
Statement Business Segments · Statement Geographical
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=mir:TechnologiesSegmentMember;srt:StatementGeographicalAxis=srt:NorthAmericaMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2024-06-30 | 62600000 | USD | 20240802 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 121200000 | USD | 20240802 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 64100000 | USD | 20240802 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 119300000 | USD | 20240802 | Open filing evidence |